George Delgado

998 total citations
17 papers, 754 citations indexed

About

George Delgado is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, George Delgado has authored 17 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 4 papers in Infectious Diseases and 4 papers in Clinical Biochemistry. Recurrent topics in George Delgado's work include Antimicrobial Resistance in Staphylococcus (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Reproductive Health and Contraception (3 papers). George Delgado is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Reproductive Health and Contraception (3 papers). George Delgado collaborates with scholars based in United States, United Kingdom and Canada. George Delgado's co-authors include Susan L. Davis, Corey Largman, Hidekazu Tsukamoto, Samuel W. French, Nancy C. Benson, G. Ananda Rao, Edward C. Larkin, Michael J. Rybak, Peggy S. McKinnon and Robert D. Welch and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and Biochemical Pharmacology.

In The Last Decade

George Delgado

17 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Delgado United States 10 197 176 153 136 127 17 754
Mohammad Sistanizad Iran 16 117 0.6× 146 0.8× 62 0.4× 17 0.1× 84 0.7× 87 730
Joseph M. Swanson United States 18 365 1.9× 58 0.3× 32 0.2× 84 0.6× 40 0.3× 63 1.1k
Jennifer L. Goldman United States 18 234 1.2× 146 0.8× 28 0.2× 108 0.8× 73 0.6× 105 994
Bernard Campillo France 26 991 5.0× 254 1.4× 74 0.5× 95 0.7× 104 0.8× 50 2.0k
Glen Brown Canada 16 176 0.9× 73 0.4× 16 0.1× 48 0.4× 60 0.5× 46 706
John Papadopoulos United States 19 263 1.3× 121 0.7× 14 0.1× 38 0.3× 72 0.6× 93 1.1k
Linda Awdishu United States 14 73 0.4× 69 0.4× 62 0.4× 17 0.1× 70 0.6× 57 846
Afsaneh Vazin Iran 17 111 0.6× 194 1.1× 19 0.1× 34 0.3× 91 0.7× 70 788
Pramodini Kale-Pradhan United States 20 236 1.2× 242 1.4× 21 0.1× 56 0.4× 38 0.3× 72 1.3k
Willem L. Blok Netherlands 15 210 1.1× 179 1.0× 51 0.3× 33 0.2× 41 0.3× 32 1.0k

Countries citing papers authored by George Delgado

Since Specialization
Citations

This map shows the geographic impact of George Delgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Delgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Delgado more than expected).

Fields of papers citing papers by George Delgado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Delgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Delgado. The network helps show where George Delgado may publish in the future.

Co-authorship network of co-authors of George Delgado

This figure shows the co-authorship network connecting the top 25 collaborators of George Delgado. A scholar is included among the top collaborators of George Delgado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Delgado. George Delgado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Delgado, George, et al.. (2019). A case series detailing the successful reversal of the effects of mifepristone using progesterone.. PubMed. 33(1). 21–31. 9 indexed citations
3.
Delgado, George, et al.. (2017). Embryo Survival after Mifepristone: A Systematic Review of the Literature.. PubMed. 32(1). 3–18. 3 indexed citations
4.
Delgado, George. (2015). The Reversal of Mifepristone With Progesterone.. PubMed. 30(2). 169–77. 2 indexed citations
5.
Giuliano, Christopher, et al.. (2014). Impact of a phenytoin loading dose program in the emergency department. American Journal of Health-System Pharmacy. 71(21). 1862–1869. 8 indexed citations
6.
Delgado, George, et al.. (2013). Pharmacist integration into cardiac arrest response teams. American Journal of Health-System Pharmacy. 70(8). 662–667. 9 indexed citations
7.
Delgado, George, et al.. (2012). Progesterone Use to Reverse the Effects of Mifepristone. Annals of Pharmacotherapy. 46(12). 1723–1723. 16 indexed citations
8.
Kullar, Ravina, Steven Leonard, Susan L. Davis, et al.. (2011). Validation of the Effectiveness of a Vancomycin Nomogram in Achieving Target Trough Concentrations of 15–20 mg/L Suggested by the Vancomycin Consensus Guidelines. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(5). 441–448. 91 indexed citations
9.
Davis, Susan L., Peggy S. McKinnon, George Delgado, et al.. (2007). Daptomycin versus Vancomycin for Complicated Skin and Skin Structure Infections: Clinical and Economic Outcomes. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(12). 1611–1618. 69 indexed citations
10.
Levy, Phillip D., Scott Compton, Robert D. Welch, et al.. (2007). Treatment of Severe Decompensated Heart Failure With High-Dose Intravenous Nitroglycerin: A Feasibility and Outcome Analysis. Annals of Emergency Medicine. 50(2). 144–152. 111 indexed citations
11.
Delgado, George, et al.. (2006). Documentation of pharmacists’ interventions in an emergency department and associated cost avoidance. American Journal of Health-System Pharmacy. 64(1). 63–68. 120 indexed citations
12.
Davis, Susan L., George Delgado, & Peggy S. McKinnon. (2005). Pharmacoeconomic Considerations Associated with the Use of Intravenous-to-Oral Moxifloxacin for Community-Acquired Pneumonia. Clinical Infectious Diseases. 41(Supplement_2). S136–S143. 34 indexed citations
13.
Delgado, George, Jeffrey F. Barletta, Salmaan Kanji, et al.. (2002). Characteristics of Prophylactic Antibiotic Strategies after Penetrating Abdominal Trauma at a Level I Urban Trauma Center: A Comparison with the EAST Guidelines. The Journal of Trauma: Injury, Infection, and Critical Care. 53(4). 673–678. 12 indexed citations
14.
Delgado, George, Melinda M. Neuhauser, David T. Bearden, & Larry H. Danziger. (2000). Quinupristin‐Dalfopristin: An Overview. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(12). 1469–1485. 49 indexed citations
15.
Tsukamoto, Hidekazu, George Delgado, Roger D. Reidelberger, & Corey Largman. (1986). Effects of Cholecystokinin, Food Intake and Cephalic Stimuli on Plasma Levels of Amylase, Lipase, and Immunoreactive Cationic Trypsinogen in Rats. Digestion. 35(2). 69–77. 4 indexed citations
16.
Tsukamoto, Hidekazu, H. Sankaran, George Delgado, et al.. (1986). Increased pancreatic acinar content and secretion of cationic trypsinogen following 30-day continuous ethanol intoxication in rats. Biochemical Pharmacology. 35(20). 3623–3629. 10 indexed citations
17.
Tsukamoto, Hidekazu, Samuel W. French, Nancy C. Benson, et al.. (1985). Severe and Progressive Steatosis and Focal Necrosis in Rat Liver Induced by Continuous Intragastric Infusion of Ethanol and Low Fat Diet. Hepatology. 5(2). 224–232. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026